XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.3
STOCK-BASED COMPENSATION
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION

NOTE 11. STOCK-BASED COMPENSATION

 

AYRO 2020 Long Term Incentive Plan

 

The Company has reserved a total of 1,229,956 shares of its common stock pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, including shares of restricted stock that have been issued. The Company has 822,843 stock options, restricted stock and warrants remaining under this plan as of September 30, 2023.

 

Stock-based compensation, including restricted stock awards and stock options is included in the unaudited condensed consolidated statement of operations as follows:

 

   2023   2022   2023   2022 
   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
   2023   2022   2023   2022 
Research and development  $6,219   $5,269   $18,017   $15,069 
Sales and marketing   1,999    6,001    7,488    19,816 
General and administrative   214,681    320,911    706,263    888,959 
Total  $222,899   $332,181   $731,768   $923,844 

 

Options

 

The following table reflects a summary of stock option activity:

 

 

       Weighted Average   Contractual Life 
   Number of Shares   Exercise Price   (Years) 
Outstanding at December 31, 2022   97,240   $49.20    7.56 
Forfeitures   (58,544)   7.76      
Outstanding at September 30, 2023   38,696   $87.67    6.79 

 

Of the outstanding options, 27,460 were vested and exercisable as of September 30, 2023. At September 30, 2023, the aggregate intrinsic value of stock options vested and exercisable was $0.

 

The Company recognized $15,165 and $18,821 of stock option expense for the three months ended September 30, 2023, and 2022, and $46,698 and $44,899 for the nine months ended September 30, 2023, and September 30, 2022, respectively. Total compensation cost related to non-vested stock option awards not yet recognized as of September 30, 2023, was $53,321 and will be recognized on a straight-line basis through the end of the vesting periods through April 2025. The amount of future stock option compensation expense could be affected by any future option grants or by any forfeitures.

 

Restricted Stock

 

       Weighted 
   Number of   Average Grant 
   Shares   Price 
Outstanding at December 31, 2022   82,570   $15.28 
Granted   95,087    6.00 
Vested   (61,364)   5.95 
Outstanding at September 30, 2023   116,293   $8.58 

 

 

On February 1, 2023, pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, the Company granted 95,087 shares of restricted stock to non-executive directors at a value of $6.00 per share. There are no vested and unissued shares of restricted stock awards as of September 30, 2023. As of September 30, 2023, 116,290 shares of restricted stock remain unvested and unissued.

 

The Company recognized compensation expense related to all restricted stock during the three months ended September 30, 2023, and 2022 of $207,716 and $313,360 and for the nine months ended September 30, 2023, and 2022 $686,869 and $878,945, respectively. Total compensation cost related to non-vested restricted stock not yet recognized as of September 30, 2023, was $220,741.